10x Genomics has begun shipping Atera - putting unprecedented spatial biology capabilities in researchers’ hands
The company is also announcing today Sentira, a new analysis platform to turn complex biological data into experimental conclusions. 10x's Chief Technology and Strategy Officer, Michael Schnall-Levin walks us through today's announcements. LEARN MORE ABOUT ATERA #sponsored
9 hours ago
From Basel: TOLREMO Therapeutics is working on cancer resistance - the company is targeting CBP/p300 just stared phase 1 data at World Lung
CEO Stefanie Fluckiger-Mangual describes the rationale for targeting CPB/p300 and walks us through TOLREMO's recently presented phase 1 data, which had a clean safety profile and showed evidence of anti-tumor activity. Coverage brought to you by
9 hours ago
From Basel: Forty51 Ventures was formed in Basel four years ago and has a company building model - they look globally, but believe that having the pharma company pipeline in Basel is an advantage
Co-Founder & Partner Sascha Oliver Bucher describes the firm and investments it has been making, and shares his thoughts on the VC ecosystem in Europe. Coverage brought to you by
1 day ago
.png){kind=logo}